Atterx Biotherapeutics
PrivateLast Round
Convertible Debt
Mar 31, 2025
Total Funding Raised
$12.98M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Atterx Biotherapeutics is a biotechnology company that develops novel therapies to combat multi-drug resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atterx Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Atterx Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 31, 2025 | ||||
| Early Funding | Jan 13, 2023 | ||||
| Series C Extension | Jun 1, 2022 | ||||
| VC Round | Apr 25, 2016 | ||||
| Series B | May 14, 2010 | ||||
Grant | Oct 24, 2008 |
Atterx Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boomerang Catapult | Series C Extension, Early Funding |
| Northern Michigan Angels | Early Funding |
| U.S. Department of War | Grant |
| Michigan Rise | Early Funding |
| Michigan Strategic Fund | Early Funding, Convertible Debt |
| Wisconsin Investment Partners | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 39% MoM, reaching 1.2K.
- May 21, 2026
Monthly visitors increased 45% MoM.
Atterx Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atterx Biotherapeutics's valuation, stock price, and market status.